Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Recommended reconstitution by protocol phase This phased approach uses different vial sizes at different stages, matching the vial to the dose rather than forcing one size to work across all phases
NHS costs differ due to procurement arrangements and are not equivalent to private list prices
received research support from Cerenovus Inc, Medtronic, Endovascular Engineering, Frontier Bio, Sensome Inc, Endomimetics, Ancure LLC, Neurogami Medical, MIVI Biosciences, Monarch Biosciences, Stryker, Conway Medical, Piraeus Medical, Rion Inc, and Bionaut Labs
"Improved survival with vemurafenib in melanoma with BRAF V600E mutation"
US$ 27.01
US$ 21.77
US$ 27.77
US$ 27.67
US$ 26.77
